Evidence map›Paper›PMID 34532319›Full record

ArticleFrontiers in cell and developmental biology2021

iPS Cell-Based Model for

Tabea Strauß, Amir Marvian-Tayaranian, Eldem Sadikoglou, Ashutosh Dhingra, Florian Wegner, Dietrich Trümbach, Wolfgang Wurst, Peter Heutink, Sigrid C Schwarz, Günter U Höglinger

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Tabea StraußGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Amir Marvian-TayaranianGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Eldem SadikoglouGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Ashutosh DhingraGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Florian WegnerDepartment of Neurology, Hanover Medical School, Hanover, Germany.
Dietrich TrümbachInstitute of Developmental Genetics, Helmholtz Zentrum München, Oberschleißheim, Germany.
Wolfgang WurstGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Peter HeutinkGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Sigrid C SchwarzGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Günter U HöglingerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
German Center for Neurodegenerative Diseases · DEMedizinische Hochschule Hannover · DETechnical University of Munich · DEHelmholtz Zentrum München · DEHertie Institute for Clinical Brain Research · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

The H1 haplotype of the microtubule-associated protein tau (

Indexed as

disease modelingiPSCMAPT haplotypeNGN2 neuronsTAUα-SYNUCLEIN

Identifiers

PMID34532319
PMCPMC8438159
OpenAlexW3197782569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.